Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 1190-53-0 | Product Number: B6007
Buformin Hydrochloride
×
![]()
×
Purity: >95.0%(HPLC)
Synonyms:
- N-Butylbiguanide Hydrochloride
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 50MG |
$46.00
|
1 | Contact Us | Contact Us |
|
| 250MG |
$160.00
|
Contact Us | Contact Us | 9 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | B6007 |
| Purity / Analysis Method | >95.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__6H__1__5N__5·HCl = 193.68 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container | 50MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 1190-53-0 |
| Reaxys Registry Number | 3627999 |
| PubChem Substance ID | 468590843 |
| Merck Index (14) | 1476 |
| MDL Number | MFCD00045591 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Melting point | 174.0 to 178.0 °C |
| Elemental analysis(Nitrogen) | 34.30 to 38.00 % |
Properties (reference)
| Melting Point | 176 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H315 + H320 : Causes skin and eye irritation. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P362 : Take off contaminated clothing and wash before reuse. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
Transport Information:
| HS Number | 2925.29.9000 |
Application
Buformin Hydrochloride: A Biganide Antidiabetic
Buformin hydrochloride is a biganide antidiabetic such as metformin [M2009] and phenformin. They delay absorption of glucose from the gastrointestinal tract, increase insulin sensitivity and glucose uptake into cells, and inhibits synthesis of glucose by the liver.1) Although, buformin and phenformin were withdrawn from the clinical market in many countries due to an elevated risk of causing lactic acidosis which is a condition characterized by overproduction of lactic acid.2,3) Meanwhile, it has been reported that biganide antidiabetics inhibit the growth and development of cancer.4,5) (The product is for research purpose only.)
References
- 1) Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- 2) Buformin concentrations in a case of fatal lactic acidosis
- 3) Buformin suppresses the expression of glyceraldehyde 3-phosphate dehydrogenase
- 4) Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation
- 5) Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat
- 6) Determination of antihyperglycemic biguanides in serum and urine using an ion-pair solid-phase extraction technique followed by HPLC-UV on a pentafluorophenylpropyl column and on an octadecyl column
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.